Planetary Technologies

The firm targets the bioeconomy — companies developing biological alternatives to petrochemical-based industrial processes. This includes synthetic biology platforms, precision fermentation, alternative proteins, bio-based materials, and carbon-to-value technologies. The firm invests across early and growth stages, primarily in North America.

The firm operates as a private equity fund manager with a single thematic mandate around the bioeconomy. It does not publicly disclose fund structures, specific vehicles, or capital raised. The Seattle-based firm appears to run a concentrated thesis rather than a multi-strategy platform.

The firm's narrow posture on bio-industrial transformation separates it from broad climate-tech platforms. Rather than investing across renewable energy, mobility, and carbon markets, Planetary Technologies concentrates solely on companies using biology to replace fossil-fuel chemistry in manufacturing and materials supply chains.

The firm's primary footprint is North America, with an emphasis on the Pacific Northwest and Bay Area biotech clusters. There is no public record of dedicated offices outside Seattle or formal expansion into European or Asian bioeconomy markets.

Based on its private equity designation and early-to-growth-stage strategy, the firm invests in private companies. There is no indication of a public-equities, credit, or infrastructure sleeve within the firm's mandate.